Abstract Background Coronavirus disease 2019 (COVID-19) continues to be a major global
public health challenge, with the emergence of variants of severe acute respiratory …

Аннотация Представлены данные о процессе репродукции SARS-CoV-2 и
рассмотрены возможные мишени для фармакологических веществ. Изложены …

Enzyme inhibitors are frequently used to treat viral illnesses. Protease inhibitors are a
promising class for combating novel and life-threatening viral infections. This research …

Non-structural protein 10 (nsp10) and non-structural protein 16 (nsp16) are part of the RNA
synthesis complex, which is crucial for the replication of severe acute respiratory syndrome …

目的观察盐酸氨溴索治疗新型冠状病毒肺炎的临床疗效和安全性. 方法选取2020 年1–6
月在石家庄市第五医院住院的68 例新型冠状病毒肺炎患者, 随机分为对照组和观察组, 每组34 …

La PCR en tiempo real para virus respiratorios ha ampliado el diagnóstico etiológico de la
neumonía adquirida en la comunidad (NAC), pero, a pesar de un trabajo de diagnóstico …

With the ongoing pandemic declared by the World Health Organization, the number of
hospitalizations and deaths caused by COVID-19 is increasing dramatically. As new variants …

Abstract “Undruggable” or “difficult to drug” targets make up most of the human proteome;
these proteins are described as such when it is considered impossible to pharmacologically …

The COVID-19 epidemic has put health systems around the world in distress, at the same
time stimulating global research in an attempt to discover new therapeutic strategies against …

Dengue viruses (DENVs) are the etiological agent of the world's most aggressive arthropod-
borne disease. At present, there are no available antivirals against DENVs. This fact …